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Abstract
Psychiatric disorders such as schizophrenia and autism are characterised by cellular disorganisation and dysconnectivity
across the brain and can be caused by mutations in genes that control neurodevelopmental processes. To examine how
neurodevelopmental defects can affect brain function and behaviour, we have comprehensively investigated the
consequences of mutation of one such gene, Semaphorin-6A, on cellular organisation, axonal projection patterns, behaviour
and physiology in mice. These analyses reveal a spectrum of widespread but subtle anatomical defects in Sema6A mutants,
notably in limbic and cortical cellular organisation, lamination and connectivity. These mutants display concomitant
alterations in the electroencephalogram and hyper-exploratory behaviour, which are characteristic of models of psychosis
and reversible by the antipsychotic clozapine. They also show altered social interaction and deficits in object recognition
and working memory. Mice with mutations in Sema6A or the interacting genes may thus represent a highly informative
model for how neurodevelopmental defects can lead to anatomical dysconnectivity, resulting, either directly or through
reactive mechanisms, in dysfunction at the level of neuronal networks with associated behavioural phenotypes of relevance
to psychiatric disorders. The biological data presented here also make these genes plausible candidates to explain human
linkage findings for schizophrenia and autism.
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Introduction
There is compelling evidence that many psychiatric disorders
have their origins in disturbed neurodevelopment [1,2,3].
Widespread cellular disorganization as well as long-range
structural dysconnectivity in schizophrenia (SZ) [4,5,6], bipolar
disorder (BD) [7,8,9] and autism spectrum disorders (ASD)
[10,11,12,13,14] are consistent with primary defects in cell
migration, axon guidance and/or synaptogenesis in many brain
areas. These findings are also consistent with symptoms in these
disorders across many psychological domains and brain systems
(cognitive, affective, social, motor and perceptual). There is
considerable shared genetic risk across these disorders
[15,16,17], as well as epilepsy [18,19] and mental retardation
[20]. These disorders can be caused by single mutations in any of a
large number of loci [17,20,21,22,23], and many of the putatively
causal mutations predispose to more than one disorder [20].
Strikingly, many of the genes implicated have crucial roles in
neurodevelopmental processes [20,22,24,25,26,27]. These various
disorders may thus represent more or less distinct phenotypic
endpoints arising from common neurodevelopmental insults.
Collectively, the genes so far identified explain only a small
fraction of disease cases. Evolutionary genetic theory suggests there
must be many such genes that can be mutated to cause disorders
such as SZ, in order to maintain the high prevalence of the
disorder in the face of strong negative selection [23,28]. Other
neurodevelopmental genes are thus good a priori candidates to
contribute to the etiology of psychiatric disorders.
From this perspective, genes in the semaphorin and plexin
families emerge as promising candidates [29]. The transmembrane
semaphorin Semaphorin-6A (Sema6A) interacts with the trans-
membrane proteins Plexin-A2 and Plexin-A4, and, along with
Sema6B, these proteins co-ordinately control axon guidance
[30,31], laminar connectivity [32,33,34], neuronal migration
[35,36] and dendrite development [37]. Mutation of Sema6A
results in widespread but subtle derangements of cytoarchitecture
and neuronal connectivity in various parts of the brain
[30,31,32,33,36,38,39,40].
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Semaphorin genes have been previously implicated in psychi-
atric disorders. In humans, variants in PLXNA2 [41,42,43] have
been associated with risk for SZ and variants in SEMA6A with risk
for ASD [44]. Furthermore, alterations in expression levels of
multiple semaphorins, plexins or semaphorin signalling proteins
have been observed in the cortex of post mortem schizophrenia
[45,46] or autism [47] patient brains [45,46] and in animal models
of NMDA-receptor blockade [48], which model psychosis in
humans.
In this paper, we provide a comprehensive survey of
neuroanatomical defects in Sema6A mutant mice, which include
previously unreported limbic and cortical cellular disorganisation
and dysconnectivity. Some of these changes resemble the reported
neuropathology in ASD and SZ. We also characterise these
animals ethologically and in a broad panel of behavioural tests and
analyse global neural activity patterns using electroencephalogra-
phy. We find that Sema6A mutants display electrophysiological and
behavioural phenotypes that phenocopy some of the defects
observed in accepted animal models of SZ and that can be
reversed by antipsychotics. We consider these results in light of
association and linkage findings in humans for loci encoding
SEMA6A and interacting proteins.
Results
Neuroanatomical phenotypes in Sema6A mutant mice
As neurodevelopmental mutations typically affect multiple brain
regions, any of which might contribute to behavioural or
physiological phenotypes in mice or to the broad array of
symptoms in humans, we set out to comprehensively characterize
the anatomical defects across the brain due to Sema6A mutation.
We were particularly interested, however, in areas most strongly
implicated in the psychopathology of psychiatric disorders,
including the prefrontal cortex and limbic system, which had not
been previously investigated in these mutants.
Prefrontal cortex. The prefrontal cortex in rodents
encompasses the agranular insular cortex, the orbitofrontal
cortices and some of the cingulate cortices [49]. Some neurons
in these areas normally send axons to the opposite hemisphere
across the posterior limb of the anterior commissure (pAC). In
embryonic (E16–17.5, n= 3, not shown) and newborn (postnatal
days (P)0–2, n= 9) Sema6A homozygous mutants, all axons of the
pAC project ventromedially rather than medially and fail to cross
the midline (Figure 1A,B). Many misrouted pAC axons can be
found in adult Sema6A2/2 mice (n= 5, Figure 1C,D), where
they extend into the hypothalamus and septum (Figure 1E–I).
Retrograde tracing of pAC axons in homozygous mutant animals
also reveals that the cell bodies of these neurons are ventrally
misplaced and located within piriform, rather than insular cortex,
where they are observed in control animals (Supporting
Information S1).
Piriform cortex and olfactory structures. Staining for
PLAP, Nissl, or with anti-NeuN antibodies at various ages
highlighted a dramatic change in morphology of the piriform
cortex in Sema6A homozygous mutants. This three-layered
structure receives direct input from the olfactory bulb and
connects reciprocally with prefrontal cortex and many other
structures [50]. In Sema6A mutants, the folding of the piriform
cortex, most readily visualized in the densely packed cells of layer
2, is greatly exaggerated and is evident far further caudally than
normal (Figure 2A, B; see also Figure 1A–D and 2G–N). In
addition, axons from the lateral olfactory tract (LOT), which
normally extend very superficially along the surface of the piriform
cortex (Figure 2C, G–I) are displaced internally in Sema6A
mutants at E16.5 (Figure 2E, F) and in adulthood (Figure 2K–N)
and also extend considerably further caudally (Figure 2D, F, and
I–N).
Neocortex. Staining with Nissl, anti-NeuN antibodies or
DAPI also revealed a defect in the cellular organisation of the
neocortex (n = 14 in total; adult: Nissl, n = 4; DAPI, n= 5; NeuN,
n= 3; P10: NeuN, n= 2). In Sema6A2/2 animals, the normally
distinct border between layers 1 and 2 is difficult to distinguish, as
many neurons from layers 2/3 invade into the normally cell-sparse
neuropil of layer 1 (Figure 3A, B). This defect is not evident at late
embryonic stages (E16.5–E17.5) but can be observed from P3
onwards (data not shown).
Hippocampal formation. We performed antibody staining
for NeuN, a marker of mature neurons, and Prox1, a marker for
postmitotic granule cells in the hippocampal dentate gyrus, on
brain sections at P10 (Figure 4A–F). In Sema6A2/2 mice, we
found a subtle but consistent malformation of the infrapyramidal
(lower) blade of the dentate gyrus. At the tip of this blade, many
misplaced Prox1-positive granule cells were observed, producing a
broadened or forked appearance of the tip. In addition, isolated
ectopic granule cells were frequently observed within the
molecular layer on the infrapyramidal side, some close to the
ventricular wall (Figure 4D–F, arrows). These misplaced cells
persist in the adult (Figure 4G–J).
We also observed defects in long-range connectivity of the
hippocampus. In Sema6A mutants, the post-commissural fornix is
often defasciculated and reduced in size, sometimes containing far
fewer axons than normal. This phenotype is quite variable, even
from one side of the brain to the other (Figure 4K, L). On average,
the cross-sectional area of the fornix was significantly reduced
(p,0.05, T-Test, Figure 4M) to 83.7% (69 vs. 100% 617.0 in
Sema6A+/2), as was the degree of compactness (measured by the
ratio of actual vs. circular perimeter: 2.5360.66 in Sema6A2/2 vs.
1.8260.08 in Sema6A+/2; p,0.01, T-Test, Figure 5N).
With the exception of the defect in the fornix and some aspects
of the previously reported corticospinal tract defect [30], all the
anatomical phenotypes we observe are fully penetrant (i.e.,
observable qualitatively across all mutant animals analysed).
Alterations in cortical physiology
We used scalp electroencephalography to examine general
levels of cortical activity in Sema6A mutants. Sema6A2/2 animals
showed a greater spectral density (total power) than Sema6A+/2
mice (42,20065,668, n= 4 vs. 20,01066,671 mv/Hz, n= 3,
respectively; Figure 5A,B) in a cortical electroencephalograph
(EEG). Spectral analysis revealed a significant and specific increase
in power in the alpha band (8–13 Hz; p,0.001) in Sema6A2/2
compared to Sema6A+/2 animals (Figure 5C). Administration of
clozapine (0.25 mg/kg) resulted in normalisation of alpha power
to levels comparable to heterozygous controls (Figure 5D), which
showed no significant effect of clozapine on alpha power.
Behavioural analyses
We set out to characterise, in an unbiased fashion, the
behavioural consequences of mutation of Sema6A, using a broad
panel of behavioural tests, along with ethological observation in
the home cage environment.
Analysis of gait in Sema6A2/2 mutants revealed a significantly
shorter hind stride length in Sema6A2/2 mice relative to wild-type
(WT or Sema6A+/+) controls (Figure 6A; genotype: F2, 39 = 3.24,
P,0.05, Figure 6A). A marginally significant increase in hind/
front overlap was also observed in Sema6a2/2 mice (Figure 6B;
genotype: F2, 33 = 2.89, p = 0.07), as well as a mean decrease in
front stride length (WT vs. Sema6A2/2: 3.3 cm60.15 vs.
Sema6A Mutants Model Psychopathology
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3.1660.07) and hind base width (WT vs. Sema6A2/2:
2.61 cm60.10 vs. 2.3860.07), although neither of these differ-
ences were statistically significant (Figure 6A; p.0.05). Examina-
tion of grip strength during the wire hang suspension task failed to
reveal any genotypic differences (p.0.05, not shown).
Examination of open-field exploratory locomotor activity in
Sema6A2/2 mice revealed a hyperactive phenotype in both sexes,
as indexed by significant increases in activity counts (Figure 6C;
genotype: F2, 46 = 4.78, p,0.05) and distance travelled (Figure 6D;
genotype: F2, 46 = 5.65, p,0.05) over a 6-hour observation period.
Relative habituation of exploration to the novel environment did
not differ between genotypes (genotype6hours interaction:
F10, 230 = 1.02, p= 0.429). Ethologically-based assessment of
exploratory behaviours in a novel environment (the ethogram
[51]) revealed significant increases in locomotion and rearing in
mutants relative to controls (data not shown and Figure 7I). Prior
treatment with the antipsychotic clozapine (0.25 mg/kg) reversed
the hyper-exploratory phenotype in Sema6A2/2 mice (Figure 6E;
genotype6drug interaction: F 4, 67 = 3.37, p,0.05) to a level
indistinguishable from wild-type littermate control mice treated
with vehicle or clozapine. Treatment with haloperidol (0.5 mg/kg)
reduced control activity count values somewhat, though not
significantly (from 2526+/2284 (SEM) in 8 vehicle-treated
animals, to 1637+/2545 in 7 haloperidol-treated animals,
p = 0.16), but completely reversed the hyperlocomotion in Sema6A
mutants (from 5116+/2837 to 1556+/2192, n= 8 and 7,
respectively, p,0.01). The NMDA-receptor antagonist MK-801
(0.2 mg/kg) stimulated locomotor activity in both Sema6A2/2
mice and controls, with no treatment-genotype interaction;
additionally, Sema6A2/2 mice did not show any differential
responsiveness to a subthreshold dose of MK-801 (0.05 mg/kg)
relative to controls (Figure 6F; genotype6drug treatment interac-
tion; F4, 56 = 0.67, p.0.05). Heterozygous animals were not
significantly different from wild-type in gait or locomotion tests.
Recognition memory was examined in the Novel Object
Recognition (NOR) paradigm. Sema6A2/2 mice demonstrated
Figure 1. Prefrontal cortex dysconnectivity in Sema6A mutants. We visualized pAC projections using the placental alkaline phosphatase
(PLAP) marker encoded in the Sema6A mutant allele [38]. During development, PLAP is expressed in the neurons that form the pAC (Figure 1A, B),
while in adults, the PLAP marker is expressed by oligodendrocytes and thus labels all myelinated axons (Figure 1C, D). In newborn Sema6A2/2 mice
(B), the PLAP-stained pAC axons travel ventrally into hypothalamic areas and fail completely to cross the midline as seen in Sema6A+/2 mice (A). Such
misrouted pAC axons are still present in adult Sema6A2/2 brains (C, compare with Sema6A+/2 in D) and can be found through extended levels of the
caudo-rostral axis within inappropriate regions, such as the septum (E-I, arrowheads). The aAC and stAC are normal in young and adult Sema6A2/2.
a/p/stAC: anterior/posterior/stria terminalis arm of the anterior commissure; Pir: piriform cortex; Scale bar in (A) is for (A, B), in (C) is for (C, D), and in
(E) is for (E–I): 500 mm.
doi:10.1371/journal.pone.0026488.g001
Sema6A Mutants Model Psychopathology
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increased exploration of both objects relative to wild-type controls
during the sample phase (WT vs. Sema6A2/2: t14 = 2.16, p= 0.05)
and during test 1 (Figure 7A; WT vs. Sema6A2/2: t14 = 2.19,
p,0.05). Sema6A2/2 mice evidenced impairment in the NOR
task, as indexed by decreased exploration of the novel object
compared to the familiar object at the 1-hr retention interval
(Figure 7B; WT vs. Sema6A2/2: t14 = 2.18, p,0.05). Sema6A
2/2
mice were also examined for spatial working memory in the
spontaneous alternation task. Impaired performance, as indicated
by decreased alternation across the three arms of the Y maze, was
observed in male Sema6A2/2 mice relative to wild-type controls
(Figure 7C; t16 = 2.98; p,0.01). This was accompanied by an
increase in total number of arm entries, a measure of activity levels
in this task (WT vs. Sema6A2/2: t16 = 2.85, p,0.05). These effects
were not observed in females.
Emotionality and anxiety-related behaviour were examined in
Sema6A2/2 mice in the elevated plus maze. Male Sema6A2/2 mice
demonstrated decreased anxiety, as evidenced by increased
percent time spent in the open arms relative to the enclosed arms
of the maze (Figure 7E; WT vs. Sema6A2/2: t18 = 2.36, p,0.05).
The hyperactive phenotype of Sema6A2/2 mice was also evident in
this measure, in terms of an increased number of overall arm
entries vs. wild-type controls for both sexes (Figure 7E; genotype:
F2, 57 = 10.304, p,0.0001). No falls from the open arms of the
maze were noted for WT or Sema6A2/2 animals, indicating no
effect of genotype on overall sensorimotor function in this task.
Figure 2. Defects in piriform cortex and olfactory projections. (A, B) NeuN-immunohistochemistry of coronal P10 brains sections
demonstrates a greatly exaggerated folding of the piriform cortex in Sema6A2/2 (B), compared to Sema6A+/2 mice (A). (C–F) E16 Sema6A+/2 (C, D)
and Sema6A2/2 (E, F) brain sections immunostained for L1 (green) to label all fibres and for Neuropilin-1 (NP-1) to label more specifically LOT axons.
In Sema6A2/2 mutants, the L1/NP-1 double-stained LOT (yellow) appears rounded and more embedded into layer 1 of the piriform cortex (E) in
contrast to a superficially located LOT in Sema6A+/2 mice (C). In addition, the LOT extends far further caudally than normal (compare F and D). (G–N)
Series of PLAP-stained adult brain sections, showing persistence of a more rounded and displaced LOT (arrowheads) that extends further caudally in
Sema6A2/2 mutants (K–N) when compared with Sema6A+/2mice (G–J). Note also that adult Sema6A2/2mutants show an exaggerated folding of the
pirifom cortex, which extends far caudally. Ia: agranular insular cortex; lot: lateral olfactory tract; Pir: piriform cortex. Scale bar in (A) is for (A, B):
200 mm; in (C) is for (C–D): 100 mm; in (G) is for (G–N): 500 mm.
doi:10.1371/journal.pone.0026488.g002
Sema6A Mutants Model Psychopathology
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When tested in an alternative assay of anxiety, marble-burying
behaviour, both male and female Sema6A2/2 mice demonstrated
an anxiolytic phenotype, as measured by fewer marbles buried,
relative to wild-type controls (Figure 7G; t39 = 2.17, p,0.05).
Social interaction, including various affiliative and agonistic
behaviours, was assessed in Sema6A2/2 and wild-type controls by
placing them with an unfamiliar age-, sex-, and weight-matched
C57/BL6 mouse in a novel environment. Sema6A2/2 mice
displayed increased social sniffing episodes towards an unfamiliar
mouse relative to controls (Figure I; genotype: F2, 29 = 7.403,
p,0.05). This increase in social investigative behaviour was
accompanied by a decrease in walkover episodes (genotype: F2,
29 = 7.403, p,0.01) and walkover time (genotype: F2, 29 = 4.33,
p,0.01) compared to control mice, indicating a reduction in social
dominance-related behaviour (Figure 7H and I).
Discussion
The results described above implicate Sema6A in the control of
neurodevelopmental processes across the brain, including novel
and important functions in the developing hippocampus and
cortex. Convergent findings from physiological, behavioural and
pharmacological experiments also suggest that the neurodevelop-
mental defects observed in Sema6A mutants result in endopheno-
types that parallel some aspects of psychiatric disorders.
Our findings extend the functions of Sema6A in cell migration
to various areas of the brain, including the hippocampus, piriform
cortex and neocortex. They also extend its role in axon guidance
to the lateral olfactory tract, anterior commissure and fornix. A
new trend that is apparent is the role of Sema6A in restricting
neuronal cell bodies from areas of neuropil and in the organisation
of distinct tracts within neuropil. One interesting question is how
this disorganisation or misrouting of axons affects connectivity. For
the axons of the posterior limb of the anterior commissure it is
clear that they are misrouted into the ipsilateral hypothalamus and
septum but we have not ascertained whether they make functional
connections there; they clearly do not make functional connections
with their normal targets in the contralateral hemisphere. Analysis
of the connectivity of misplaced cells in the cortex and
hippocampus will require electrophysiology at the microcircuit
level (e.g., [52]).
Our focus in this paper is not on the primary functions of
Sema6A in these processes, however, nor on using these
phenotypes to understand how Sema6A works in neural
development. These questions have previously been addressed in
many different areas of the developing nervous system
[30,31,32,33,36,38,39,40]. Our interests here are in cataloguing
the spectrum of anatomical defects in these mutants and
examining their combined effects on the functioning of the
nervous system, as assessed at the physiological and behavioural
Figure 3. Aberrant lamination of the neocortex. NeuN-immunostaining of coronal sections of adult Sema6A+/2 (A, A1–3) and Sema6A2/2
(B, B1–3) mouse brains in overview (A, B) and detailed view (A1–3, B1–3; position in A, B is indicated as boxes). While the border between layers 1 and
2 of the neocortex is sharply visible in Sema6A+/2 animals (A1–3), it is largely obliterated in Sema6A2/2 mutants (B1–2), and the neuropil of layer 1
appears infiltrated by neurons from deeper layers with a gradient in severity from lateral to medial (B). Laterally, many ectopic neurons form repetitive
clusters (asterisks in B1) bordered by neuropil. More medially these neurons are more loosely scattered within the neuropil over a considerable depth
(arrowheads in B2, B3). 1–6: Cortical layers 1 to 6. Au: auditory area; S1: primary somatosensory area; PtA: parietal association area. Scale bar in (A) is
for (A, B): 500 mm; in (A1) is for (A1–3,B1–3): 200 mm.
doi:10.1371/journal.pone.0026488.g003
Sema6A Mutants Model Psychopathology
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levels, in order to explore the possible relevance of such effects to
the etiology of neurodevelopmental disorders in humans. It is
important to note that Sema6A may also have additional functions
in adults, in synaptic plasticity or related processes, for example,
which could also contribute to the physiological and behavioural
phenotypes we observe.
We consider the phenotypes observed in Sema6A mutants in the
context of what is known of the neuropathology, pathophysiology
and pharmacology of psychiatric disorders, especially SZ and
ASD. Given that each of these diagnostic categories most likely
represents a collection of disorders with diverse etiologies, these
comparisons are necessarily general. We also compare the defects
Figure 4. Alterations in hippocampal lamination and projections. (A–F) Immunohistochemistry for NeuN (A, D; green, neurons) and Prox1 (B,
E; red, dentate granule cells; overlay in C and F) on coronal brain sections from P10 Sema6A+/2 (A–C) and Sema6A2/2 (D–F) mice. Sema6A2/2 mice
show a broadening of the granule cell layer at the tip of the infrapyramidal blade of the dentate gyrus as well as more isolated clusters of ectopic
granule cells at the surface of the molecular layer of the same blade (arrows in D–F). (G–H) Overlays of NeuN- (green) and Prox1- (red) immunostained
adult brain sections of Sema6A+/2 (G) and Sema6A2/2 (H–J). Similarly distributed ectopic granule cells (arrows in H–J) are still present in the adult
dentate gyrus. (K–L) PLAP-stained adult brain sections showing a reduced and defasciculated fornix (Fx) in Sema6A2/2 (L, left fornix) compared with
Sema6A+/2 mice (K). The fornix is significantly reduced in size by 20% (M; p,0.05) and is significantly less compact (N; measured as the ratio of actual
and circular perimeter; p,0.01) in Sema6A2/2 (n = 10) compared to Sema6A+/2 mice (n = 8). Error bars in (M, N) represent 6 SD; *: significant. Dots
plotted on the right of columns in (N) are individual data points. Scale bar in (A) is for (A–F), in (G) is for (G–J), and in (K) is for (K, L): 200 mm.
doi:10.1371/journal.pone.0026488.g004
Figure 5. Altered cortical activity patterns. (A) Representative bilateral cortical EEG traces from Sema6A2/2 and Sema6A+/2 animals in
spontaneous, freely moving conditions. (B) Quantification of total spectral power in Sema6A+/2 (n = 3) and Sema6A2/2 (n = 4) animals, p,0.005. (C)
Quantification of relative power of spectral bands in Sema6A+/2 (n = 7) and Sema6A2/2 (n = 8); a significant increase in the alpha band was observed
p,0.001. (D) Increase in relative power in the alpha band in Sema6A2/2 is reversed by administration of clozapine, p,0.05. No significant effect of
clozapine on alpha power in Sema6A+/2 animals was observed (n = 4 for all groups). Clozapine at this dose did not affect the other spectral power
bands in either genotype (not shown). *p,0.05; ns: non-significant. Error bars represent 6 SEM.
doi:10.1371/journal.pone.0026488.g005
Sema6A Mutants Model Psychopathology
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Figure 6. Gait abnormalities and hyperlocomotion. (A) Gait analysis indicated significantly shorter hind-stride length in Sema6A2/2 mutants
compared to controls (p,0.05). (B) There is a trend towards decreased hind-front overlap in Sema6A2/2 mutants (p = 0.07). (C) Sema6A2/2 mutants
displayed increased number of ambulatory counts in the open-field over a six-hour period (n = 20 per genotype; p,0.05). (D) Sema6A2/2 mutants
demonstrated increased exploratory behaviour in the open-field, as indexed by greater distance travelled over a six-hour period (p,0.05). (E)
Clozapine (0.25 mg/kg) significantly reversed the hyper-exploratory phenotype in Sema6A2/2 mutants without altering exploration in controls (n = 8
per treatment with vehicle or drug, and per genotype; p,0.05). (F) MK-801-induced hyperlocomotion (0.2 mg/kg) did not differ across the genotypes
(n = 8 per treatment with vehicle or drug, and genotype). *p,0.05, **p,0.01; ns: non-significant. Error bars represent 6 SEM.
doi:10.1371/journal.pone.0026488.g006
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Figure 7. Memory defects, decreased anxiety, and increased social interaction. (A) In the novel object recognition task, Sema6A2/2
mutants demonstrated increased absolute levels of exploration of a novel object at both retention intervals (1 hr, 4 hr; WT: n = 9, Sema6A2/2: n = 8;
p,0.05). (B) Sema6A2/2 mutants displayed a disruption in novel object recognition memory, as indexed by decreased relative preference to explore
the novel object at the 1-hr retention interval, when compared to controls (p,0.05). No interaction with sex was observed for either of these effects.
NOR performance at the 4-hr retention interval did not differ from chance (50%) across the genotypes. (C) Spontaneous alternation test of working
memory revealed a sex-specific deficit in working memory performance in Sema6A2/2males (n = 8), as indicated by a decrease in percent alternation,
relative to controls (n = 10; p,0.01). (D) A hyper-exploratory phenotype of male Sema6A2/2 mutants was demonstrated by increase in number of
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PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e26488
observed here to those seen in mouse mutants of validated
psychiatric disease genes or non-genetic models of psychiatric
disorders.
Comparison with the pathology of psychiatric disorders
Neuropathological studies of post mortem brains of SZ patients
provide evidence for variable and subtle cytoarchitectural
disturbances in cell positioning, packing, density and size in
various parts of the brain, most notably the prefrontal cortex,
hippocampal formation [4], thalamus [53] and cerebellum
[54,55]. A general comparison with the phenotypes observed in
Sema6A mutants suggests at least a qualitative similarity, with small
numbers of misplaced cells in various brain regions. For example,
misplaced clusters of neocortical layer 2 cells and ectopic neurons
in the white matter have been repeatedly observed in post mortem
brains of SZ patients [56,57].
In ASD, neuropathological studies have similarly highlighted a
number of aberrations in the cellular organization of the cortex
[11]. These include irregular lamination, ectopic neurons in layer
1 (the molecular layer) and in the white matter and irregular
clumping of neurons in the grey matter [58,59,60], implicating a
primary defect in cortical cell migration. Ectopic granule cells have
also been observed in the molecular layer of the dentate gyrus and
of the cerebellum [60], both of which we also observe in Sema6A
mutants (this study and [39]). It should be noted that for both SZ
and ASD, no single phenotype is seen in all cases, presumably
reflecting the underlying heterogeneity of genetic causes [20,22].
Despite the expected phenotypic heterogeneity, diffusion-
weighted neuroimaging studies have yielded broadly consistent
findings of dysconnectivity in limbic, thalamocortical and
intracortical tracts in SZ and BD [5,6,7,8,9,61,62,63], some of
which parallel those in Sema6A mutants remarkably closely (this
study and [40]). These include a well-replicated disorganization
and reduction in the cross-sectional area of the fornix [64,65,66],
which has been quantitatively correlated with impairment on
several memory tasks [67,68,69]. Similar analyses in ASD also
reveal widespread alterations in structural connectivity [70].
Pathology in SZ and ASD also extends to motor and sensory
systems, consistent with symptoms in these domains [71].
Implicated motor systems include the cerebellum [13,54,55] and
corticospinal tract [70,72], where we have previously described
defects in Sema6A mutants [30,39]. The abnormalities in gait that
we report here may reflect disrupted cellular organisation in the
cerebellum [73]. Deficits in early visual processing in SZ patients
[74] are consistent with well-replicated observations of reduced
connectivity between lateral geniculate nucleus and primary visual
cortex [6,61,75,76] and a reduction in the size of primary visual
cortex [77], both of which are observed in adult Sema6A mutants
[40].
Behavioural phenotypes and alteration in cortical
physiology
Sema6A mutants display robust hyper-exploratory behaviour
and hyperlocomotion, both of which are seen across multiple test
environments. Detailed analysis of the ethogram, which evaluates
the naturalistic behavioural repertoire, shows that this hyperac-
tivity is not accompanied by an increase in stereotypic behaviours
but reflects both increased locomotion and increased exploration,
thus implicating motivational as well as motor systems.
Hyperlocomotion is arguably the most consistently observed
phenotype across many genetic, surgical or pharmacological
preclinical models of SZ [27,51,78,79,80,81], including mutants
in DISC1 [82,83,84], Nrg1 [85] and NPAS3 [86], ventral
hippocampal lesion models [87] and chronic or acute treatment
with NMDA-receptor blockers [88,89] or amphetamine
[78,79,90,91,92,93], both of which can induce psychotic states
in humans. Importantly, the hyperlocomotion in Sema6A mutants,
as in these other models, is reversible by treatment with
antipsychotics, demonstrating the predictive validity of this
phenotype as a model for psychosis and differentiating it from
hyperlocomotion induced by drugs such as nicotine.
Most of these animal models are also characterised by a
hyperdopaminergic state [78,90,91,94,95]. This is highly congru-
ent with findings in humans where a psychotic state is associated
with an increase in dopamine release and/or responsiveness [96].
Alterations in dopamine signalling may thus represent a final
common pathway to psychosis, one which can be induced through
a wide variety of insults [94,97,98].
The amphetamine sensitisation model, which directly alters
dopaminergic signalling and which is well accepted as a model of
psychosis [79,93], is also characterised by an EEG phenotype that
is highly similar to that observed here in Sema6Amutants – namely,
a selective increase in alpha power [99]. Similar results have been
reported in a number of other animal models with a hyperdopa-
minergic state [100,101,102].
These comparisons thus suggest that both the hyperactivity and
the EEG phenotype in Sema6A mutants may be associated with
alterations in dopaminergic signaling. The fact that both are
reversible by antipsychotics that target D1 and D2 receptors is
highly consistent with such a hypothesis. We have not, however,
observed significant differences in Sema6A mutants in tonic
dopamine levels or in the abundance of D2 receptors in striatum
or prefrontal cortex (Supporting Information S1). Nevertheless, it
remains possible that there is increased acute release of or response
to dopamine under certain conditions, as seen in DISC1 mutants,
for example [103] or altered levels of specific isoforms of D2
receptors that we have not assayed [98]. We note that early
disruptions to hippocampal circuitry are known to induce circuit-
level homeostatic mechanisms altering dopaminergic tone or
responsiveness in the prefrontal cortex and striatum [87,104].
Whether the defects we observe in hippocampal circuitry in
Sema6A mutant mice could be having such an effect will require
further investigation. It is also possible that these phenotypes are
caused by disturbances in other systems that can be compensated
for by altering dopaminergic signalling.
Cognitive phenotypes
Sema6A mutants also display some evidence for cognitive
phenotypes, including deficits in working memory and novel
overall arm entries in the alternation task relative to controls (p,0.05). (E) In the elevated plus maze test of anxiety, male Sema6A2/2 mutants exhibit
decreased anxiety as measured by an increase in the number of open arm entries (WT: n = 10 Sema6A2/2: n = 9; p,0.05). (F) Sema6A2/2 mutants
demonstrate an increase in number of overall arm entries in the elevated plus maze relative to controls (p,0.01). (G) Sema6A2/2 mutants of both
sexes (n = 19) exhibited decreased anxiety in the marble burying task, as indicated by a decreased number of marbles buried compared to controls
(n = 22 WT, 19 Sema6A2/2; p,0.05). (H) Assessment of social interaction with a novel conspecific revealed a decrease in duration of time spent
engaged in walkover behaviours (p,0.05) in Sema6A2/2 mutants (n = 11) relative to controls (n = 9). (I) Sema6A2/2 mutants displayed an increase in
number of anogenital sniffing (p,0.05) and decrease in walkover (p,0.01) episodes relative to controls. An increase in general exploration of the
novel environment was also observed (wall and free rearing). Error bars represent 6 SEM.
doi:10.1371/journal.pone.0026488.g007
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object recognition [26,79]. Impairment in spatial working memory
is considered a core cognitive deficit in SZ [105], and is observed
in many relevant animal models [79]. The fact that the working
memory defect is only evident in males indicates that this defect is
not simply a result of increased locomotor activity, which is seen in
both sexes in this and other tests. However, further examination of
working memory processes using more complex maze task variants
are required to characterize the nature and severity of this putative
deficit.
Defects in novel object recognition can be induced by NMDA-
R blockers or by methamphetamine sensitisation [79] and NOR is
considered a valid animal model of human declarative memory
[106], which is frequently impaired in SZ. A deficit in this test
could alternatively arise due to altered salience. This would be
consistent with the increased exploration of both known and novel
objects that we observe in Sema6A mutants. Though speculative,
the latter explanation would also fit with a model of hyperdopa-
minergia [79], which is linked to salience-related effects in humans
with psychosis [107,108].
Sema6A mutants show an anxiolytic profile across two measures
of anxiety-related behaviour, which cannot be explained with
reference to the observed hyper-exploratory phenotype. Mice
mutant for the Sema3E gene also demonstrate reduced anxiety in
the elevated plus maze, which may be attributable to a defect in
the fornix of these animals [109], suggesting a similar possible
explanation in Sema6A mutants. The effect on anxiety in Sema6A
mutants is particularly interesting in light of the strong association
of PLXNA2 variants with anxiety in humans [110].
Links to the etiology of psychiatric disorders in humans
The phenotypic spectrum described here suggests that muta-
tions in SEMA6A in humans would likely result in a psychiatric
presentation of some sort. SEMA6B, PLXNA2 and PLXNA4 are
similarly implicated by virtue of their biochemical and genetic
interactions and overlapping spectrum of anatomical phenotypes
when disrupted [30,31,32,33,35,36,37]. Though no discrete
mutation in any of these genes has yet been discovered in human
patients, there is convergent evidence implicating either their
chromosomal regions or common polymorphisms in the genes
themselves.
SEMA6A falls in one of the best-replicated linkage peaks for SZ,
on 5q23, first discovered in Irish families [111,112]. A study using
dense mapping in extended Swedish pedigrees identified a
haplotype inherited identical by descent in the 5q23.1 region,
segregating in individuals diagnosed with SZ [113]. This
haplotype is restricted to a 6.8 Mbp region, which encompasses
sixteen genes, one of which is SEMA6A. Rare deletions of the 5q23
region, which include the SEMA6A locus, have been found in
patients with mental retardation and SZ [114,115,116].
PLXNA2 is also located in a tightly replicated linkage peak for
SZ and for periodic catatonia at 1q32.2 [117,118,119]. In
addition, both SEMA6B and PLXNA4 fall near the maxima of
very tightly defined linkage peaks for autism, derived from
multiplex pedigrees, on 19p13.3 [120] and 7q32.2 [121],
respectively. Given the phenotypes described above, these genes
are plausible candidates to underlie these linkage findings.
PLXNA2 also emerged as the top candidate from a whole-
genome case-control association analysis of SZ in a population of
European descent [41]. This result was replicated in several
independent samples [41,42], though not in all populations
[41,122,123]. Nevertheless, a comprehensive meta-analysis ranked
PLXNA2 among the top SZ risk-associated genes [43]. SEMA6A
has been recently associated with ASD, in a novel genome-wide
association analysis method [44].
We have replicated evidence for an association of PLXNA2
variants and SZ risk in a case-control study from the Irish
population, though only at a statistically suggestive level
(Supporting Information S1). We also found suggestive evidence
for an association with variants in SEMA6A and SEMA6B and a
stronger epistatic interaction between the associated variants in
PLXNA2 and SEMA6B (Supporting Information S1). Biological
epistatic interactions between these genes have been documented
in the control of hippocampal connectivity in mice [33],
highlighting the plausibility of such an interaction. Given the
effect sizes and p-values, the associations we observe may be false
positives. If real, they could represent either a small effect of a
common variant on risk in individuals or a larger effect of a linked,
but more highly penetrant mutation that is much rarer in the
population [124]. Such mutations would be difficult to detect in
large-scale genome-wide association studies that combine samples
across populations. Whether disease-causing variants in these
genes exist in human populations will thus require further
investigation.
In summary, we present evidence that mutation of the Sema6A
gene results in widespread defects in cellular organisation and
axonal projections, some of which resemble those reported in ASD
and SZ. This demonstrates that this kind of neuropathology can
arise directly from mutations in a gene controlling cell migration
and axon guidance. We also show that these mutants display a
behavioural and physiological profile with similarities to accepted
animal models of SZ, particularly the positive symptoms of
psychosis. We do not propose that these mutants provide a model
for SZ or ASD as a whole. These disorders are so heterogeneous
that it is unlikely that any single mutant mouse or even any
individual human patient could model the entire spectrum of
either of these diseases. However, Sema6A mutants may provide an
informative model to investigate how defects in neurodevelop-
mental processes, can, through either primary or reactive
mechanisms, cause neuronal network and circuit dysfunction
and ultimately result in a specific profile of behavioural deficits of
relevance to psychopathology in humans. Given these findings,
SEMA6A and the genes encoding interacting proteins become
interesting candidates to explain some of the linkage findings for
SZ, BD and ASD in their respective chromosomal loci.
Materials and Methods
Animal use
All animal procedures were performed in accordance with the
European Communities Council Directive (86/609/EEC). Those
carried out at Trinity College were reviewed and approved by the
Trinity College BioResources Committee under license B100/
3527 (licence holder: KJM) from the Department of Health,
Dublin, Ireland. Those carried out at the Royal College of
Surgeons in Ireland were approved by the Research Ethics
Committee of the Royal College of Surgeons in Ireland REC 092
REC205A and were conducted under licenses B100/759 (licence
holder: JLW), B100/962 (licence holder: CO’T) and B100/3248
(licence holder: MD) from the Department of Health and
Children.
Genotyping
Genotyping of Sema6A mice was carried out as previously
described [30].
Histology
PLAP staining was carried out as previously described [38], as
were tracings with lipophilic DiI and immunhistochemistry [30].
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The following antibodies were used: rat anti-L1 (Chemicon),
mouse anti-NeuN (Chemicon), goat anti-Neuropilin-1 (R&D
Systems), rabbit anti-Prox1 (Chemicon).
Electroencephalography
EEG recordings and analyses were carried out essentially as
described [125]. There was no significant difference in weights
between Sema6A homozygotes and heterozygotes. Female mice
were anesthetized using isoflurane (5% induction, 1–2% maine-
nence in O2). Mice were placed in a stereotaxic frame (David Kopf
Instruments, CA, USA) and body temperature maintained at
3760.5uC by means of a homeostatic blanket and heat lamp
(Harvard Apparatus, MA, USA). Following a midline incision
Bregma was located and three partial burr holes drilled bi-
temporally overlying the hippocampi and a third on the midline
over the frontal cortex. Cortical EEG was recorded by means of
skull-mounted recording electrodes (Plastics One Inc, VA, USA)
fixed with dental cement. Electrodes were connected to a Comet
EEG acquisition system (Grass-Telefactor, USA) and recordings
commenced. Right and left side EEG was recorded for Sema6A
heterozygous and homozygous mice for 20 minutes, during which
5-second segments were selected and spectral analysis performed
for left and right sides. Baseline EEG was recorded for 20 min
followed by injection of clozapine (0.25 mg/kg i.p.) and continued
for 40 min post-injection. EEG spectral analysis was divided into
standard frequency bands (beta, theta, alpha, delta) and the
relative input into total spectrum of each band was calculated
automatically by an in-built feature of the analysis software (Twin,
Grass-Telefactor, USA) for 5 s epochs. For technical reasons, it
was not possible to estimate gamma frequency power from these
recordings. Baseline values were calculated in the 5 min pre-
injection. The signal was analysed 25 min. post injection, since
altered clozapine-induced behaviour has been shown to emerge at
this time. All data are expressed as mean 6 SEM.
Behavioural Analyses
Footprint Test. The footprint test was used to assess gait
[126]. Black and red paint was daubed on the hind- and forefeet,
respectively, of each mouse. Animals were then permitted to walk
along a brightly lit 34 cm-long, 14 cm-wide runway (10-cm-high
perspex walls) into a darkened box lined with sample of bedding
from mouse’s home cage. A sheet of white paper lined the floor of
the runway. The following parameters were measured (cm): Stride
length – average distance between each stride; hind-base width –
average distance between left and right hind footprints; front-base
width - average distance between left and right front footprints;
left-right overlap – difference from left or right front footprint/
hind footprint overlap.
Wire-hang suspension. Grip strength was assessed in the
wire-hang suspension task [127]. Each mouse was placed on a wire
net (30635 cm) with plastic borders along its sides. The wire
netting was given a quick shake and turned upside down (approx.
30 cm above a worktop). The amount of time that each mouse
held onto the wire was recorded up to a maximum of 300 s.
Elevated-plus maze. Anxiety-related behaviour was assessed
using the elevated plus maze test as described [128]. Two opposing
arms were surrounded by cream-coloured chipboard walls (12 cm
high, closed arms); the other two walls were devoid of walls (open
arms). The apparatus was elevated 25 cm above ground level. The
test was conducted under dim lighting conditions. At the start of
test, the mouse was placed in the centre of the maze, facing one of
the open arms. Number of entries into each arm, as well as
cumulative time spent in open and closed arms was recorded
during a 5 min session. Entry into an open arm was defined as all
four paws being placed in that arm. The maze was cleaned
between trials with 3% VirkonTM (Antec International, USA). The
start of each trial coincided with the mouse’s first arm entry.
Marble-burying task. In the marble-burying task, mice
were individually placed in clear perspex boxes (33615613 cm),
containing 25 glass marbles (diameter 21.5 cm) evenly spaced on
sawdust (depth-5.2 cm). Mice were not allowed access to food and
water. Marble-burying behavior was defined as the number of
marbles buried at least two-thirds deep in the sawdust within
30 min.
Monitoring of activity in a novel environment. Locomotor
activity was assessed in the open field. Each mouse was placed
individually in the center of an open field apparatus (ENV-510;
27.9627.9 cm; Med Associates, St. Albans, VT). Total ambulatory
counts, distance traveled (cm), and vertical activity were recorded.
Data were collected over a 60-min period.
Reversal of hyperactivity following antipsychotic admi-
nistration. Activity was measured in mice pre-treated with the
atypical antipsychotic clozapine (0.25, 0.5, 1.0 mg/kg) or the
typical antipsychotic haloperidol (0.5 mg/kg). Animals were
brought from the holding facility into the experimental room.
They were then weighed and injected s.c. with vehicle or drug and
placed back in their home cages. 20–25 minutes later, each mouse
was placed individually in the open field apparatus (ENV-510;
27.9627.9 cm; Med Associates, St. Albans, VT) and several
indices of activity (see above) were recorded over a 60-min period.
Clozapine (Sigma/RBI, St. Louis, MO) was dissolved in 50 ml
0.1 M HCL and diluted in distilled water. Haloperidol (Sigma, St.
Louis, MO) was dissolved in glacial acetic acid and diluted in
distilled water. Vehicle consisted of 50 ml 0.1 M HCL – distilled
water. All solutions were prepared fresh daily and injected in a
volume of 4 ml/kg.
MK-801 induced hyperactivity. Animals were brought
from the holding facility into the experimental room. They were
then weighed and injected s.c. with vehicle or MK-801 (0.2 mg/
kg) and returned to their home cages. 20–25 minutes later, each
mouse was placed individually in the open field apparatus (ENV-
510; 27.9627.9 cm; Med Associates, St. Albans, VT) and several
indices of activity (see above) were recorded over a 60-min period.
MK-801 (Sigma/RBI, St. Louis, MO) was dissolved in distilled
water. Vehicle consisted of distilled water. All solutions were
prepared fresh daily and injected in a volume of 4 ml/kg.
Social interaction in a novel environment. In the test of
social interaction in a novel environment, mice were individually
paired with an unfamiliar age-, weight- and sex-matched C57BL6
mouse in a novel observation chamber (28628616 cm) for a
10 min observation period. The chamber was constructed of clear
perspex and clean bedding material was placed on the chamber
floor prior to each test. Between each test, the chamber floor and
walls were cleaned with 3% VirkonTM (Antec International, USA).
Both the test mouse and the unfamiliar C57BL6 conspecific were
placed in the chamber simultaneously and this placement defined
the start of the trial. For each animal, the test was captured and
recorded using a digital camcorder mounted above the chamber at
ceiling level. The experimenter was blind to genotype at time of
test and during the subsequent coding of behaviours. All social and
nonsocial exploratory behaviours were later coded using the
Observer H (Noldus Inc., The Netherlands) video analysis
software. Nine behaviours were coded and organised into the
following behavioural domains: social investigation (anogenital
sniffing – sniffing of anogenital region of conspecific), social
dominance (walkover– the mouse places its front paws on the head
or back of conspecific; aggressive following – the test mouse
rapidly follows the conspecific from behind, forcing it to retreat),
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agonistic behaviours (pinning – the mouse pins the conspecific to
the floor; clawing), nonsocial exploration (rearing to wall; rearing
free – the mouse is upright with front paws raised; sifting – the
mouse sifts through the bedding). All behaviours coded were those
initiated by the test mouse.
Spontaneous alternation memory. The continuous variant
of the Y-maze spontaneous alternation procedure was assessed
during one 10 min session. The Y-maze apparatus consisted of
three identical arms (40612.5640 cm). Without prior habituation,
each test mouse was placed at the centre of the Y-maze and
allowed to move freely throughout the maze for a single 10 min
period. Rodents possess a natural preference to explore areas
previously un-explored; if a mouse has explored one arm of the Y-
maze, it is not expected to enter the same arm during its next
phase of exploration, but to enter one of the two alternate arms;
this test has been suggested to measure several aspects of spatial
working memory [129]. A video camera, mounted centrally above
the Y-maze, recorded each session and allowed alternation to be
analysed using video tracking software (EthovisionH, Noldus Inc.,
the Netherlands). Spontaneous alternation was defined as
successive entries into the three arms, in overlapping triplet sets.
It is expressed as a percentage and refers to the ratio of arm
choices differing from the previous two choices to the total number
of arm entries: percent alternation= ((number of alternations/total
number of arm entries) – 2)6100 [129]. The experimenter was
blind to genotype at time of test.
Novel object recognition. Recognition memory was
assessed using the novel object recognition paradigm with short
(1 hr) or long (4 h) retention times, respectively. The apparatus
consisted of an open arena (29629620 cm) covered by a layer of
bedding (depth 2.5 mm) surrounded by a black cardboard wall.
The objects (A, B, C) were two golf balls (diameter 5 cm) with a
dimpled surface texture, a blue and a green opaque hollow plastic
disc (diameter 4.5 cm, height 2.5 cm) with two small holes in
surface, and two pink plastic LegoH bricks (dimensions
563.562.5 cm)) with 8 protrusions. The experiment was
conducted under standard room lighting.
Habituation phase. Twenty four hours prior to testing, mice
were placed in the arena and allowed to explore freely for two
consecutive sessions of thirty minutes each, with an inter-session
interval of 15 min; mice were returned to their home cage
between habituation sessions. The arena was wiped clean using
5% Virkon and bedding replaced, both between each session for a
given animal and between each experimental animal.
Sample phase. For testing, mice were first allowed to explore the
arena for two further sessions of 30 min separated by an inter-
session interval of 15 min. Then, two identical objects, A1 and A2,
were placed at the rear left and right corners of the arena, 5 cm
from both walls to facilitate exploration around each object. Each
test mouse was placed at the midpoint of the wall opposite to the
sample objects, with nose facing the wall and hence away from
objects so as to remove any unintentional bias and allowed to
explore the arena for 5 min. Time spent interacting with each
object was recorded manually. At the conclusion of this 5 min
period, the test mouse was returned to its home cage, the arena
cleared of bedding and both arena and objects wiped down to
remove odour traces.
Test Phase 1. Following an inter-trial interval of 1 h, the test
mouse was placed in the arena now containing familiar object A1
and novel object B1 for 5 min. Time spent interacting with each
object was recorded manually for 5 min.
Test Phase 2. Following an inter-trial interval of 4 h (i.e. the
period between completing Test Phase 1 and initiating Test Phase
2), the test mouse was placed in the arena now containing familiar
object B1 and novel object C1. Time spent interacting with each
object was recorded manually for 5 min. The sequence of object
presentation was counterbalanced between animals (i.e. which
object served as sample or trial object). Similarly, the position of
novel and familiar objects was counterbalanced between trials (i.e.
novel or familiar object placed in left or right corner of arena).
Time spent interacting with each object was determined as nose or
whiskers touching the object or directed towards it within ,1 cm,
or touching the object with a paw. Accidental contact with object
(i.e. bumping or using the object as a platform to explore the
arena) was not counted as interaction with the object. The
experimenter was blind to genotype at time of test and during the
subsequent coding of behaviours.
Statistical Analyses. Analysis of behavioural data followed
procedures similar to those described previously [50], using
between- or within-subjects analysis of variance (ANOVA), as
appropriate, with main factors of genotype, sex, and/or drug
treatment; post-hoc comparisons were carried out using independent
or paired t-tests, corrected for multiple comparisons. Gait measures
were analysed in terms of total length for each measure; exploration
in a novel environment was analyzed in terms of activity counts and
distance travelled over 1–6 h of habituation; exploration in a novel
environment following prep-treatment with an antipsychotic or
MK-801 was analyzed in terms of activity counts; spontaneous
alternation was analyzed in terms of percentage alternation and
number of arm entries; novel object recognition was analyzed in
terms of time exploring the novel object during the sample phase,
test phase 1, and test phase 2; social interaction was analyzed in
terms of total number of episodes and total duration of each
behaviour; the EPM was analyzed in terms of absolute or
percentage time spent in, and number of entries into, each arm;
marble burying was analysed in terms of total number of marbles
left uncovered. For the above phenotypic measures, we
hypothesized that genotype would be modulated by sex [50];
thus, where appropriate, separate t-test analyses were also
conducted within male and female groups. All statistical analyses
were carried out using the SPSS software package (Version 14,
SPSS, Chicago, IL, USA).
High-performance liquid chromatography analysis
Tissue constituting three brain areas (frontal cortex, striatum,
hippocampus) was removed from each of 16 mice (3 Sema6A+/2
male, 4 Sema6A2/2 male, 4 Sema6A+/2 female, 5 Sema6A2/2
female). All were 10 weeks old, except for 2 female homozygous
mutants, which were 15 weeks old. Tissue was weighed and put
into 500 ml HPLC buffer (buffer was previously run through
HPLC column to get baseline standards), sonicated to homoge-
nise, centrifuged 10 min at 1000 g and stored at 270uC until use.
100 ml of each sample was analysed by HPLC to ascertain levels of
dopamine and serotonin and their metabolites 3,4-Dihydroxyphe-
nylacetic acid (DOPAC), homovanillic acid (HVA) and 5-
Hydroxyindoleacetic acid (5-HIAA).
Supporting Information
Supporting Information S1 This file contains detailed infor-
mation on cell positioning defects of anterior commissure-
projecting neurons and concentrations of neuromodulators in
various brain regions in Sema6A mutant animals. It also describes
methods and results of association analyses of variants in SEMA6A,
SEMA6B, PLXNA2 and PLXNA4 with schizophrenia in a sample
from the Irish population.
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